Track CTTH and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CTTH - CTT Pharmaceutical Holdings Inc (CTTH) has a free cash flow of -$75.47K, down 257.8% over the past year and up 4.9% per year over the past five years.
FCF TTM
-$75.47K
FCF Margin
-
FCF Yield
-2.05%
5Y CAGR
4.86%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$75.47K | -257.80% |
| 2023 | -$21.09K | +77.56% |
| 2022 | -$94.00K | +84.34% |
| 2021 | -$600.25K | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q4 2025 | -$15.28K | -23.23% |
| Q3 2025 | -$12.40K | +24.39% |
| Q2 2025 | -$16.40K | +47.75% |
| Q1 2025 | -$31.39K | -479.15% |
| Q4 2024 | -$5.42K | +68.08% |
| Q3 2024 | -$16.98K | -48.04% |
| Q2 2024 | -$11.47K | - |
| Q1 2024 | - | - |
| Q4 2023 | -$2.14K | -145.69% |
| Q3 2023 | -$871.00 | +82.63% |
| Q2 2023 | -$5.01K | +61.62% |
| Q1 2023 | -$13.07K | +31.09% |
| Q4 2022 | -$18.96K | +42.78% |
| Q3 2022 | -$33.14K | -244.98% |
| Q2 2022 | -$9.61K | +70.25% |
| Q1 2022 | -$32.29K | +94.07% |
| Q4 2021 | -$544.92K | -3680.24% |
| Q3 2021 | -$14.41K | +15.26% |
| Q2 2021 | -$17.01K | +28.85% |
| Q1 2021 | -$23.91K | - |
| Q4 2020 | - | - |
| Q3 2020 | - | - |
| Q2 2020 | - | - |
| Q1 2020 | - | - |
| Q4 2019 | - | - |
| Q3 2019 | - | - |
| Q2 2019 | - | - |
| Q1 2019 | - | - |
| Q4 2018 | - | - |
| Q3 2018 | - | - |
| Q2 2018 | -$105.72K | -252.09% |
| Q1 2018 | -$30.02K | - |
| Q4 2017 | - | - |
| Q3 2017 | - | - |
| Q2 2017 | -$55.42K | -859.73% |
| Q1 2017 | $7.29K | - |
| Q4 2016 | - | - |
| Q3 2016 | -$13.26K | -153.03% |
| Q2 2016 | $25.00K | +13055.96% |
| Q1 2016 | -$193.00 | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.